Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol
- PMID: 1295360
- DOI: 10.1007/BF02028098
Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol
Abstract
Recently, there has been an increasing interest in the involvement of adenosine as a mediator of allergic asthma. In the present study, we have employed an allergic rabbit model to study the airway responses to adenosine. The rabbit litter mates were injected i.p., within 24 h of birth, with ragweed pollen extract to preferentially produce ragweed-specific IgE. This allergic rabbit model demonstrates many clinical features of asthma similar to human allergic asthma. Aerosolized adenosine (0.156-10 mg/ml) caused a concentration-dependent bronchoconstriction. The normal rabbits (non-immunized) did not respond to adenosine within that concentration range. Theophylline significantly inhibited the adenosine-induced bronchoconstriction. These early studies suggest that adenosine differentiated asthmatic airways from normal airways and adenosine-induced bronchoconstriction in this model was mediated through specific cell surface receptor(s).
Similar articles
-
Modification of allergen-induced airway obstruction and bronchial hyperresponsiveness in the allergic rabbit by theophylline aerosol.Agents Actions. 1992 Nov;37(3-4):168-70. doi: 10.1007/BF02028099. Agents Actions. 1992. PMID: 1295361
-
Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model.Am J Physiol. 1994 Mar;266(3 Pt 1):L271-7. doi: 10.1152/ajplung.1994.266.3.L271. Am J Physiol. 1994. PMID: 8166296
-
Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor.J Pharmacol Exp Ther. 1994 Mar;268(3):1328-34. J Pharmacol Exp Ther. 1994. PMID: 8138947
-
Adenosine in the airways: implications and applications.Eur J Pharmacol. 2006 Mar 8;533(1-3):77-88. doi: 10.1016/j.ejphar.2005.12.056. Epub 2006 Feb 3. Eur J Pharmacol. 2006. PMID: 16458886 Review.
-
Purine derivatives in the study of allergic inflammation in respiratory diseases.Allergy. 1997;52(34 Suppl):48-54. doi: 10.1111/j.1398-9995.1997.tb04811.x. Allergy. 1997. PMID: 9188954 Review.
Cited by
-
Therapeutic approaches to asthma based on VLA-4 integrin and its counter receptors.Springer Semin Immunopathol. 1995;16(4):467-78. doi: 10.1007/BF00196101. Springer Semin Immunopathol. 1995. PMID: 7570296 Review. No abstract available.
-
Adenosine receptors and asthma.Handb Exp Pharmacol. 2009;(193):329-62. doi: 10.1007/978-3-540-89615-9_11. Handb Exp Pharmacol. 2009. PMID: 19639287 Free PMC article. Review.
-
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.Eur J Pharmacol. 2020 Nov 15;887:173561. doi: 10.1016/j.ejphar.2020.173561. Epub 2020 Sep 15. Eur J Pharmacol. 2020. PMID: 32946870 Free PMC article. Review.
-
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.Eur J Pharmacol. 2006 Dec 3;551(1-3):116-24. doi: 10.1016/j.ejphar.2006.08.059. Epub 2006 Sep 8. Eur J Pharmacol. 2006. PMID: 17027749 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources